|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
JP3101690B2
(ja)
|
1987-03-18 |
2000-10-23 |
エス・ビィ・２・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
GB8809129D0
(en)
|
1988-04-18 |
1988-05-18 |
Celltech Ltd |
Recombinant dna methods vectors and host cells
|
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
|
GB9019812D0
(en)
|
1990-09-11 |
1990-10-24 |
Scotgen Ltd |
Novel antibodies for treatment and prevention of infection in animals and man
|
|
US5830755A
(en)
|
1995-03-27 |
1998-11-03 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
T-cell receptors and their use in therapeutic and diagnostic methods
|
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
US5677139A
(en)
|
1995-04-21 |
1997-10-14 |
President And Fellows Of Harvard College |
In vitro differentiation of CD34+ progenitor cells into T lymphocytes
|
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
|
WO2000073348A2
(en)
|
1999-06-02 |
2000-12-07 |
Genentech, Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
|
WO2002008284A2
(en)
|
2000-07-20 |
2002-01-31 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
|
WO2002000690A2
(en)
|
2000-06-23 |
2002-01-03 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
|
WO2000078961A1
(en)
|
1999-06-23 |
2000-12-28 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US5928631A
(en)
|
1997-06-09 |
1999-07-27 |
The Procter & Gamble Company |
Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins
|
|
US20020127584A1
(en)
|
1997-09-18 |
2002-09-12 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US5932445A
(en)
|
1997-11-07 |
1999-08-03 |
Incyte Pharmaceuticals, Inc. |
Signal peptide-containing proteins
|
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
|
NZ531664A
(en)
|
1998-09-01 |
2005-07-29 |
Genentech Inc |
Pro1317 polypeptides and sequences thereof with homology to the semaphorin B glycoprotein family
|
|
AU773028B2
(en)
|
1998-11-03 |
2004-05-13 |
Adherex Technologies Inc. |
Compounds and methods for modulating claudin-mediated functions
|
|
AU3124000A
(en)
|
1998-12-17 |
2000-07-03 |
Human Genome Sciences, Inc. |
47 human secreted proteins
|
|
JP2002536995A
(ja)
|
1999-02-22 |
2002-11-05 |
インサイト・ファーマスーティカルズ・インコーポレイテッド |
結腸の疾患に関連する遺伝子
|
|
EP1514933A1
(en)
|
1999-07-08 |
2005-03-16 |
Research Association for Biotechnology |
Secretory protein or membrane protein
|
|
CA2402563A1
(en)
|
1999-12-23 |
2001-07-26 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
|
AU2001236470A1
(en)
|
2000-01-14 |
2001-07-24 |
Corixa Corporation |
Ovarian tumor-associated sequences
|
|
ES2336887T5
(es)
|
2000-03-30 |
2019-03-06 |
Whitehead Inst Biomedical Res |
Mediadores de interferencia por ARN específicos de secuencias de ARN
|
|
AU6531101A
(en)
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
AU2001273150A1
(en)
|
2000-07-20 |
2002-02-05 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030100713A1
(en)
|
2000-07-25 |
2003-05-29 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
EA013564B1
(ru)
|
2000-08-03 |
2010-06-30 |
Терапеутик Хьюман Поликлоналз Инк. |
Гуманизированный иммуноглобулин и содержащая его фармацевтическая композиция
|
|
CA2430013C
(en)
|
2000-11-30 |
2011-11-22 |
Medarex, Inc. |
Transgenic transchromosomal rodents for making human antibodies
|
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
PT2000545E
(pt)
|
2001-06-20 |
2011-12-21 |
Genentech Inc |
Composições e métodos para o diagnóstico e tratamento do tumor pulmonar
|
|
CA2379661A1
(en)
|
2002-03-28 |
2003-09-28 |
Kursad Turksen |
Paracellular drug delivery system
|
|
JP2005536190A
(ja)
|
2002-04-16 |
2005-12-02 |
ジェネンテック・インコーポレーテッド |
腫瘍の診断と治療のための組成物と方法
|
|
US20070207142A1
(en)
*
|
2002-05-08 |
2007-09-06 |
Genentech, Inc. |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
|
AU2003295328A1
(en)
|
2002-10-02 |
2004-04-23 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
BRPI0315295C1
(pt)
|
2002-10-17 |
2021-05-25 |
Genmab As |
anticorpo monoclonal humano isolado, célula hospedeira procariótica, composição farmacêutica, molécula biespecífica, usos de um anticorpo, métodos in vitro de detectar a presença de antígeno de cd20 ou uma célula que expressa cd20 em uma amostra, kit, e, vetor de expressão
|
|
AU2003303144A1
(en)
|
2002-10-18 |
2004-07-29 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
AT500651B9
(de)
|
2003-05-27 |
2010-04-15 |
Altropus Gmbh |
Aktiv immunisierender antikörper
|
|
US20050031615A1
(en)
|
2003-05-30 |
2005-02-10 |
Anderson G. Mark |
Method of inhibiting tumor growth with anti-tissue factor antibodies
|
|
US20060019256A1
(en)
*
|
2003-06-09 |
2006-01-26 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
WO2006033664A1
(en)
|
2004-03-08 |
2006-03-30 |
Avalon Pharmaceuticals |
Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods
|
|
US7431927B2
(en)
|
2005-03-24 |
2008-10-07 |
Epitomics, Inc. |
TNFα-neutralizing antibodies
|
|
DE102005025041A1
(de)
|
2005-05-30 |
2006-12-07 |
Bell Flavors & Fragrances Duft Und Aroma Gmbh |
Mittel zur Anwendung in Spülmaschinen sowie Vorrichtung für dessen dosierte Einbringung während der Spül- und Trocknungsphasen
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
EP2368908A3
(en)
*
|
2006-11-10 |
2011-10-12 |
CovX Technologies Ireland Limited |
Anti- angiogenic compounds
|
|
JPWO2008114733A1
(ja)
|
2007-03-16 |
2010-07-01 |
協和発酵キリン株式会社 |
抗Ｃｌａｕｄｉｎ−４抗体
|
|
EP1997832A1
(en)
|
2007-05-29 |
2008-12-03 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against Claudin-18 for treatment of cancer
|
|
WO2009025759A1
(en)
|
2007-08-17 |
2009-02-26 |
Progenics Pharmaceuticals (Nevada), Inc. |
Tight junction proteins associated with infection and entry of hepatitis c virus (hcv), methods and uses thereof
|
|
WO2009028663A1
(ja)
|
2007-08-30 |
2009-03-05 |
Kyowa Hakko Kirin Co., Ltd. |
抗Claudin-3抗体
|
|
EP2060583A1
(en)
|
2007-10-23 |
2009-05-20 |
Ganymed Pharmaceuticals AG |
Identification of tumor-associated markers for diagnosis and therapy
|
|
EP2241578B1
(en)
|
2008-01-11 |
2016-04-20 |
The University of Tokyo |
Anti-cldn6 antibody
|
|
WO2009120905A2
(en)
*
|
2008-03-26 |
2009-10-01 |
Cellerant Therapeutics, Inc. |
Immunoglobulin and/or toll-like receptor proteins associated with myelogenous haematological proliferative disorders and uses thereof
|
|
AU2009234259A1
(en)
|
2008-04-11 |
2009-10-15 |
Bionovo, Inc. |
Anticancer methods employing extracts of Gleditsia sinensis Lam
|
|
US9005963B2
(en)
|
2008-10-14 |
2015-04-14 |
Ablynx N.V. |
Amino acid sequences directed against cellular receptors for viruses and bacteria
|
|
DE102009026966A1
(de)
|
2008-12-18 |
2010-07-01 |
Robert Bosch Gmbh |
Betrieb eines Bremskraftverstärkers als Pedalsimulator
|
|
JP2010178650A
(ja)
|
2009-02-04 |
2010-08-19 |
Univ Of Tokyo |
固形癌の再発予測のための試験方法および再発予防剤
|
|
EP2221063A1
(en)
|
2009-02-20 |
2010-08-25 |
Ganymed Pharmaceuticals AG |
Methods and compositions for diagnosis and treatment of cancer
|
|
SMT202300421T1
(it)
|
2009-02-20 |
2024-01-10 |
Astellas Pharma Inc |
Metodi e composizioni per la diagnosi e il trattamento del cancro
|
|
EP2322555A1
(en)
*
|
2009-11-11 |
2011-05-18 |
Ganymed Pharmaceuticals AG |
Antibodies specific for claudin 6 (CLDN6)
|
|
DK3305813T3
(da)
|
2009-11-11 |
2020-04-20 |
Astellas Pharma Inc |
Antistoffer, der er specifikke for claudin 6 (cldn6)
|
|
WO2011105551A1
(ja)
|
2010-02-26 |
2011-09-01 |
国立大学法人大阪大学 |
癌幹細胞の検出方法、及び癌の治療剤または再発予防剤
|
|
JP2011213612A
(ja)
*
|
2010-03-31 |
2011-10-27 |
Kyowa Hakko Kirin Co Ltd |
癌幹細胞及び／または癌前駆細胞の減少剤
|
|
EP2404936A1
(en)
|
2010-07-06 |
2012-01-11 |
Ganymed Pharmaceuticals AG |
Cancer therapy using CLDN6 target-directed antibodies in vivo
|
|
ES2989943T3
(es)
|
2011-05-13 |
2024-11-28 |
Astellas Pharma Inc |
Anticuerpos para el tratamiento de un cáncer que expresa la Claudina 6
|
|
EP2749641B1
(en)
|
2011-09-07 |
2021-06-02 |
Chugai Seiyaku Kabushiki Kaisha |
Cancer stem cell isolation
|
|
EP2605017A1
(de)
|
2011-12-16 |
2013-06-19 |
Protagen AG |
Markersequenzen für gynäkologisches Malignom und deren Verwendung
|
|
KR101242726B1
(ko)
|
2012-01-26 |
2013-03-13 |
한국과학기술원 |
종양줄기세포 특성 암의 진단 및 치료제
|
|
EP2875046B2
(en)
|
2012-07-19 |
2025-04-30 |
Amgen Inc. |
Human btnl3 proteins, nucleic acids, and antibodies and uses thereof
|
|
JP6499079B2
(ja)
*
|
2012-11-13 |
2019-04-10 |
バイオエヌテック アーゲーＢｉｏＮＴｅｃｈ ＡＧ |
クローディンを発現するガン疾患を処置するための剤
|
|
WO2014075697A1
(en)
*
|
2012-11-13 |
2014-05-22 |
Biontech Ag |
Agents for treatment of claudin expressing cancer diseases
|
|
BR112015022855A2
(pt)
*
|
2013-03-14 |
2017-11-07 |
Shire Human Genetic Therapies |
composições e método para produção de um anticorpo in vitro
|
|
WO2015014376A1
(en)
*
|
2013-07-31 |
2015-02-05 |
Biontech Ag |
Diagnosis and therapy of cancer involving cancer stem cells
|